PQDx 0033-013-00 WHO
PQ Public Report
July/2016, version 5.0
PQDx 0197-045-00 WHO
PQDx PR
March /2016, version 2.0
PQDx 0141-051-00 WHO
PQDx Public Report
April/2017, version 5.0
PQDx 0053-006-00 WHO
PQ Public Report
June/2016, version 2.0
PQDx 0214-064-00
WHO PQDx PR
April/2016, version 3.0
PQDx 0005-005-00
WHO PQDx PR
May/2016, version 3.0
PQDx 0181-031-00
WHO PQ Public Report
March/2017, version 3.0
PQDx 0179-012-00 WHO
PQDx Public Report
June/2017, version 4.0
PQDx 0027-012-00 WHO
PQDx Public Report
May/2017, version 4.0
Every day, fake medicines and medical products are sold at street corners, in open air markets or on unregulated websites in several countries in the African Region. These poor quality, unsafe medicines and pharmaceutical products promote drug resistance and lead to loss of confidence in health prof...essionals, manufacturers and distributors and in health systems. In an effort to protect people’s health, the WHO Regional Director for Africa, Dr Matshidiso Moeti, has proposed a strategy aimed at strengthening National Medicine Regulatory Authorities (NMRAs) in order to ensure that only safe, good quality and effective medical products are available.
more
PQDx 0159-055-00
WHO PQ Public Report
February/2017, version 5.0
PQDx 0198-071-00
WHO PQDx PR
April/2016, version 2.0
Rwanda Guidelines for variation to registered pharmaceutical products.
This guideline is intended to provide requirements to applicants wishing to submit
applications for registration of medicines in Botswana.
Public Report
PQMC 0001-001-04 WHO PQMC Public Report November/2016, version 8.0
Public Report
PQMC 0003-003-00 WHO PQMC PR June/2015, version 2.0